These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25257793)

  • 1. Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews.
    Crombag NM; Vellinga YE; Kluijfhout SA; Bryant LD; Ward PA; Iedema-Kuiper R; Schielen PC; Bensing JM; Visser GH; Tabor A; Hirst J
    BMC Health Serv Res; 2014 Sep; 14():437. PubMed ID: 25257793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome.
    Boyd PA; Devigan C; Khoshnood B; Loane M; Garne E; Dolk H;
    BJOG; 2008 May; 115(6):689-96. PubMed ID: 18410651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
    Fletcher J; Hicks NR; Kay JD; Boyd PA
    BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From policy making to service use. Down's syndrome antenatal screening in England, France and the Netherlands.
    Vassy C; Rosman S; Rousseau B
    Soc Sci Med; 2014 Apr; 106():67-74. PubMed ID: 24534734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Alberman E
    BMJ; 2009 Oct; 339():b3794. PubMed ID: 19858532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
    Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
    BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester serum tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study.
    Ekelund CK; Jørgensen FS; Petersen OB; Sundberg K; Tabor A;
    BMJ; 2008 Nov; 337():a2547. PubMed ID: 19039015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influencing factors of utilization of prenatal screening for Down's syndrome].
    Gu EZ; Gu Q; Han P; Tian D; Chen YY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Apr; 46(4):307-10. PubMed ID: 22800626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the integrated test in the Down's syndrome screening algorithm.
    Springer D; Loucky J; Tesner P; Cutka D; Stejskal D; Gregor V; Zima T
    J Med Screen; 2018 Sep; 25(3):114-118. PubMed ID: 29575979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down's syndrome screening: a controversial test, with more controversy to come!
    Reynolds TM
    J Clin Pathol; 2000 Dec; 53(12):893-8. PubMed ID: 11265172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of statistics on Down's syndrome notifications.
    Huang T; Watt HC; Wald NJ; Morris JK; Mutton D; Alberman E
    J Med Screen; 1997; 4(2):95-7. PubMed ID: 9275267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Harris R; Church S; Fiddler M; Rhind J
    Br J Obstet Gynaecol; 1996 Jul; 103(7):676-83. PubMed ID: 8688395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.
    Ford C; Moore AJ; Jordan PA; Bartlett WA; Wyldes MP; Jones AF; MacKenzie WE
    Br J Obstet Gynaecol; 1998 Aug; 105(8):855-9. PubMed ID: 9746377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proportions of Down's syndrome pregnancies detected prenatally in England and Wales from 1989 to 2004.
    Morris JK; Alberman E; Mutton D
    J Med Screen; 2006; 13(4):163-5. PubMed ID: 17217603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.
    Khoshnood B; De Vigan C; Vodovar V; Goujard J; Goffinet F
    BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Down's syndrome risk assessment in Denmark--secondary publication].
    Ekelund CK; Andersen HJ; Christensen J; Ersbak V; Farlie R; Henriques C; Holmskov A; Jensen LN; Jørgensen FS; Hessellund A; Larsen T; Olesen AW; Pedersen OB; Poulsen H; Ramb J; Skibsted L; Skovbo P; Sommer S; Sperling L; Sundberg K; Juul SV; Zingenberg H; Tabor A
    Ugeskr Laeger; 2010 Jun; 172(23):1759-61. PubMed ID: 20552746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.